Approaching Chronic Spontaneous Urticaria (CSU) Associated with Hereditary or Acquired Syndromes

Initial Clinical Assessment and Red Flag Identification

The American Academy of Allergy, Asthma, and Immunology recommends systematically screening for autoinflammatory diseases, autoimmune thyroid disease, and urticarial vasculitis using specific clinical red flags and targeted laboratory testing in patients with suspected syndrome-associated CSU 1
Wheals persisting >24 hours suggest urticarial vasculitis rather than CSU, as indicated by the presence of damage to small vessels in papillary and reticular dermis 1
Symptoms such as fever, joint/bone pain, or malaise indicate possible autoinflammatory disease, which can be confirmed by elevated inflammation markers and gene mutation analysis 1

The European Academy of Allergy and Clinical Immunology suggests considering hereditary autoinflammatory syndromes, such as cryopyrin-associated periodic syndromes (CAPS) and hyper-IgD syndrome (HIDS), when family history is positive or early-onset disease is present 2
Gene mutation analysis for hereditary periodic fever syndromes and looking for neutrophil-rich infiltrates on skin biopsy can help diagnose hereditary autoinflammatory syndromes 1

The American College of Allergy, Asthma, and Immunology recommends testing for complement C4, C1-INH levels and function, and C1q and C1-INH antibodies when angioedema is prominent, to exclude hereditary or acquired angioedema 1, 2
Gene mutation analysis can help diagnose hereditary angioedema (HAE) if above tests are unremarkable but history suggests HAE 1, 2

For autoinflammatory syndromes, the primary treatment is IL-1 inhibitors, not antihistamines or omalizumab, as the underlying mechanism involves interleukin-1 rather than histamine and mast cell mediators 1
The American Academy of Allergy, Asthma, and Immunology suggests advancing earlier to cyclosporine rather than prolonged omalizumab trials for Type IIb autoimmune CSU (high IgG-anti-TPO to total IgE ratio), as this population responds poorly to antihistamines and omalizumab but well to cyclosporine 1

The American Academy of Allergy, Asthma, and Immunology recommends considering hereditary autoinflammatory syndromes, such as Cryopyrin-associated periodic syndromes (CAPS), Hyper-IgD syndrome (HIDS), and TNF-α-associated periodic syndrome (TRAPS), in patients with chronic spontaneous urticaria (CSU) 3, 4
The European Academy of Allergy and Clinical Immunology notes that acquired autoinflammatory syndromes, including Schnitzler syndrome, systemic-onset juvenile idiopathic arthritis (sJIA), and adult-onset Still disease, can also present with urticaria-like manifestations 3, 4
The British Society for Allergy and Clinical Immunology suggests testing for elevated inflammation markers, paraproteinemia, and performing gene mutation analysis for hereditary periodic fever syndromes when autoinflammatory syndromes are suspected 3

The American Thyroid Association reports that thyroid autoimmunity occurs in 14% of CSU patients compared to 6% in population controls, with elevated anti-thyroid peroxidase (anti-TPO) antibodies found in CSU patients 4
The European Thyroid Association notes that the high ratio of IgG-anti-TPO to total IgE is a surrogate marker for Type IIb autoimmune CSU, according to the American College of Rheumatology 5, 6

The American Academy of Dermatology states that urticarial vasculitis presents clinically as urticaria but shows small vessel vasculitis on histology, with wheals persisting for days rather than hours 4
The European Academy of Dermatology and Venereology notes that skin biopsy showing damage to small vessels in the papillary and reticular dermis with fibrinoid deposits distinguishes urticarial vasculitis from CSU 3, 4
The North American Society for Pediatric Gastroenterology, Hepatology and Nutrition reports a significantly higher prevalence of celiac disease in children and adolescents with severe chronic urticaria compared to case-matched controls 4